Q2 2026 Holdings
Filed 2026-08-13 | 119 holdings | $4.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| enGene Therapeutics Inc(ENGN) | COM | 29286X101 | $10.8M | 6,256,662 | 0.2% |
| Adagene Inc(ADAG) | ADS | 005329107 | $11.2M | 2,666,666 | 0.2% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $11.9M | 5,850,000 | 0.2% |
| Generate Biomedicines Inc(GENB) | COM SHS | 370920100 | $12.4M | 736,104 | 0.3% |
| CytomX Therapeutics Inc(CTMX) | COM | 23284F105 | $13.0M | 3,457,711 | 0.3% |
| Microsoft Corp(MSFT) | COM | 594918104 | $14.0M | 37,500 | 0.3% |
| Nebius Group NV(NBIS) | SHS CLASS A | N97284108 | $14.4M | 52,000 | 0.3% |
| Neumora Therapeutics Inc(NMRA) | COM | 640979100 | $14.4M | 8,497,822 | 0.3% |
| MapLight Therapeutics Inc(MPLT) | COM | 56565P103 | $16.1M | 450,000 | 0.3% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $17.3M | 3,328,287 | 0.4% |
| Nvidia Corp(NVDA) | COM | 67066G104 | $19.0M | 95,000 | 0.4% |
| Taiwan Semiconductor Manufacturing Co Ltd(TSM) | SPONSORED ADS | 874039100 | $21.3M | 44,700 | 0.4% |
| Zura Bio Ltd(ZURA) | CLASS A ORD SHS | G9TY5A101 | $22.0M | 3,734,866 | 0.4% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $23.2M | 725,000 | 0.5% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $23.4M | 900,000 | 0.5% |
| Seaport Therapeutics Inc(SPTX) | COMMON STOCK | 81221K108 | $23.8M | 1,095,316 | 0.5% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $23.8M | 250,000 | 0.5% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $25.0M | 270,118 | 0.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $25.5M | 4,458,646 | 0.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $26.6M | 1,480,586 | 0.5% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $26.7M | 641,469 | 0.5% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $26.9M | 610,515 | 0.5% |
| Absci Corp(ABSI) | COM | 00091E109 | $28.7M | 2,474,764 | 0.6% |
| Dbv Technologies SA(DBVT) | SPONSORED ADS | 23306J309 | $30.5M | 1,857,362 | 0.6% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $32.2M | 90,000 | 0.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $32.5M | 2,998,192 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $33.3M | 1,786,867 | 0.7% |
| Capital One Finl Corp(COF) | COM | 14040H105 | $34.4M | 171,615 | 0.7% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $34.5M | 1,893,410 | 0.7% |
| Remitly Global Inc(RELY) | COM | 75960P104 | $34.6M | 1,543,271 | 0.7% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $35.9M | 1,396,513 | 0.7% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $36.4M | 3,311,438 | 0.7% |
| Palvella Therapeutics Inc(PVLA) | COM | 697947109 | $39.3M | 257,485 | 0.8% |
| Taboola.com Ltd(TBLA) | ORD SHS | M8744T106 | $42.1M | 8,423,410 | 0.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $46.9M | 872,967 | 0.9% |
| Dyne Therapeutics, Inc(DYN) | COM | 26818M108 | $47.3M | 2,129,125 | 1.0% |
| Kailera Therapeutics Inc(KLRA) | COMMON STOCK | 482931102 | $48.8M | 2,214,286 | 1.0% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $53.2M | 1,420,788 | 1.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $60.8M | 4,856,949 | 1.2% |
| Septerna Inc(SEPN) | COM | 81734D104 | $63.6M | 1,900,000 | 1.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $64.7M | 758,952 | 1.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $65.0M | 888,401 | 1.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $65.3M | 1,995,347 | 1.3% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $66.8M | 1,419,493 | 1.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $67.1M | 9,846,579 | 1.4% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $68.3M | 3,650,000 | 1.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $72.0M | 1,859,279 | 1.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $74.6M | 2,420,430 | 1.5% |
| Hemab Therapeutics Holdings Inc(COAG) | COM SHS | 423494103 | $76.6M | 2,086,834 | 1.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $76.8M | 576,000 | 1.6% |